相关实验视频
Updated: Sep 13, 2025

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
577
寡合性α-synuclein导致与非运动性症状相关的皮质干路的早期突触功能障碍
Laura Bellingacci1, Miriam Sciaccaluga1,2,3, Alfredo Megaro4
1Physiology and Biochemistry Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
NPJ Parkinson's disease
|July 29, 2025
概括
寡合性α-synuclein (OSyn) 在帕金森病模型中导致早期的突触和情绪缺陷. 氨基酸Tulrampator在缓解这些早期的突触和焦虑类症状方面表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 神经药理学神经药理学
- 综核蛋白病变 (Synucleinopathies) 是一种同核蛋白病变.
背景情况:
- 阿尔法-同核素寡聚体 (OSyn) 与帕金森病 (PD) 病原发生有关.
- 早期神经毒性和促炎效应的OSyn表明在疾病发病中起着关键作用.
研究的目的:
- 为了研究由OSyn.诱导的同核蛋白病变的老鼠模型中的早期病理事件.
- 探索阿姆卡因Tulrampator在缓解早期OSyn诱导的缺陷方面的治疗潜力.
主要方法:
- 在老鼠中通过内内OSyn注射诱导同核蛋白病变.
- 电生理学评估和行为测试,以评估突触功能和行为.
- 对焦显微镜分析蛋白质表达 (VGluT1) 和聚合物形成 (p-α-syn).
主要成果:
- OSyn诱导了早期的运动,类似焦虑的行为,突触可塑性受损,神经传递减少.
- 在状末端观察到膀性谷氨酸转运体1 (VGluT1) 表达的减少.
- 图兰帕特治疗预防了突触可塑性损伤,使神经传递正常化,并改善了VGluT1水平和焦虑行为.
结论:
- OSyn在皮层-层通路中触发了早期的突触和情绪缺陷.
- 在这个模型中,tulrampator在改善早期突触和焦虑相关症状方面表现出有效性.
- 这些发现支持Tulrampator作为早期PD症状的潜在治疗策略.
相关概念视频
Neural Regulation
40.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.1K
Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669

